Glenmede Director of Investment Strategy Jason Pride, iSectors CIO Chuck Self and OptionPit.com founder Mark Sebastian on the outlook for the markets.
FBN’s Liz MacDonald on the U.S. Department of Homeland Security’s investigation into about two-dozen cases of suspected cybersecurity flaws in medical devices and hospital equipment.
FBN’s Liz MacDonald on deal stocks under pressure as the U.S. announces stricter tax rules.
FBN’s Lauren Simonetti on EMCORE’s sale of its space solar division, Integra LifeSciences’ deal with Medtronic and Sonic Drive-In.
Delphi Management Founder and president Scott Black gives his big stock picks.
FBN’s Liz MacDonald with a look at the biggest offshore cash piles.
FBN’s Lou Dobbs on Burger King’s deal to buy Canada’s Tim Hortons.
Belpointe Asset Management Chief Strategist David Nelson, FBN’s Charles Payne, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall and FBN’s Tracy Byrnes debate the outlook for Edwards Lifesciences.
Earnings HQ: FBN’s Lori Rothman breaks down Medtronic ’s first-quarter earnings report.
Jason Pride, director of investment strategy at Glenmede, offers stocks to watch.
Former CBO director Doug Holtz-Eakin and Morgan Stanley Wealth Management Head Lisa Shalett on the business and policy environment around mergers and acquisitions.
Glenmede Director of Investment Strategy Jason Pride on where to find growth in the current market, Russia’s economy, international and emerging markets.
FBN’s Liz MacDonald, Marshall Auerback of the Institute for New Economic Thinking, and Convergent Wealth Advisors CEO David Zier on exclusive details on a government group reaping the benefits of tax deserters..
Glenmede Director of Investment Strategy Jason Pride and Teddy Weisberg of Seaport Securities discuss the state of the markets and where to invest.
Glenmede Director of Investment Strategy Jason Pride and Ameriprise Financial Chief Market Strategist David Joy discuss where to put your money in the markets today.
Glenmede Director of Investment Strategy Jason Pride, Needham Growth Fund Co-Manager Chris Retzler and Ira Epstein Division of the Linn Group’s Ira Epstein on the outlook for the markets.
A&G Capital CIO Hilary Kramer on how investors can gain from the M&A activity.
Bacterin CEO Dan Goldberger on the impact on the business and jobs of the medical device tax.
Vining Sparks’ Marty Mosby and Former White House Economic Advisor Todd Buchholz discuss the markets and the midterm elections.
FBN’s Liz MacDonald on vulnerability of medical devices to cyber flaws.